Archives: Agenda
Biotech Market Outlook 2025: Implications for clinical trials and the CRO landscape
- Current biotech funding and pipeline trends shaping early and late phase development
- How market dynamics are influencing trial initiation and program design in 2025
- Shifts in CRO selection and strategic approaches among emerging biotechs
Strategies for successful recruitment and retention into clinical trials
- Discuss methods for identifying and engaging the right patient population
- Learn strategies for reducing barriers to participation
- Focus on enhancing site and investigator engagement training, tools, and incentives
- Building trust – communication and transparency takeaways
KEYNOTE: Demystifying AI: Practical insights for pharma and biotech professionals
- Includes clear, relatable examples of how AI is practically applied within healthcare and pharma, empowering executives without deep technical backgrounds
Chair’s Opening Remarks
Registration and Refreshments
Reception Drinks Sponsored by XX
Chairman’s Final Remarks & Close of Conference
Available for Sponsorship – Accessing the New AI Superforce (Interactive Workshop)
Can you transform capabilities to par with human cognition? Accelerate your artificial intelligence to super intelligence to have open-ended abilities to learn, adapt and deliver. Demos, case studies and sneak peaks to alter your performance.
Synthetic Data Generation Meets LLM-as-a-Judge: A New Era of GenAI Evaluation
This session will delve into innovative approaches for evaluating Generative AI models using synthetic data and LLM-based techniques. I will share insights on how synthetic data—generated by LLMs—can simulate real-world interactions, enabling more robust and scalable evaluation frameworks. As the GenAI Evaluation Lead for Manulife Asia, I will also present practical applications and best practices.